$1 million given for endowment of UMAB chair Research will focus on drugs for elderly

December 13, 1990

A major pharmaceutical company said yesterday that it will donate $1 million for the world's first endowed professorship in the study of drugs and the elderly at the University of Maryland at Baltimore.

The endowed chair, a gift by Parke-Davis, a division of the Warner-Lambert Co., will be dedicated to the study of geriatric pharmacotherapy, a health science that aims at reducing the risk of medication to the elderly. The company said it was making the gift in recognition of the contributions of a UMAB professor and assistant dean of the School of Pharmacy, Peter P. Lamy, whose scholarship in the field has brought him worldwide attention.

The gift comes 12 years after Dr. Lamy founded the first academic center on pharmacy and therapeutics for the elderly on the UMAB campus and after a decade of collaboration with Parke-Davis. Research at the center focuses on safer and more effective use of medications by elderly people by matching patients with appropriate drugs and dosages.

Dr. Lamy's drug education programs for the elderly, including brochures and award-winning television programs, have attracted a national following among health care workers. He is the author of "Prescribing for the Elderly" and has published more than 275 papers in geriatrics and gerontology.

David A. Knapp, acting dean of the School of Pharmacy, said the gift would allow the university to continue its partnership with Parke-Davis and focus attention "on an area that cries out for nurturing -- the use of medications by older persons."

Baltimore Sun Articles
Please note the green-lined linked article text has been applied commercially without any involvement from our newsroom editors, reporters or any other editorial staff.